KADMON HOLDINGS

 KDMNのチャート


 KDMNの企業情報

symbol KDMN
会社名 Kadmon Holdings Inc (KADMON HOLDINGS)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 カドモン・ホールディングス(Kadmon Holdings Inc)(旧名: Kadmon Holdings LLC)は小分子・バイオ製剤の発見・開発・商業化に従事するバイオ医薬品会社である。同社は自己免疫・繊維性・腫瘍・遺伝性疾患の治療向けの候補製品を開発する。同社は腫瘍治療のKD025とTesevatinib、多発性嚢胞腎(PKD)治療のTesevatinib及びKD034を含む。同社はRibasphere RibaPak、Ribasphereタブレット、Ribasphere、Qsymia、Tetrabenazine及びValganciclovirを含む錠剤・カプセルを提供する。KD025は経口選択的ROCK2 阻害剤であるrhoキナーゼ2プラットフォームにおける候補製品である。Tesevatinibは腫瘍増殖・転移・薬物耐性のドライバー分子を阻害する経口チロシン・キナーゼ阻害薬(TKI)である。KD034は体内の過剰銅を除去するキレート化合物である塩酸トリエンチン製剤のウィルソン病治療のポートフォリオである。  カドモン・ホ―ルディングスは米国のバイオ医薬品持株会社。子会社を通じ、バイオ製剤の開発・商業化に従事する。自己免疫機能を取り入れ、線維性疾患、がん、遺伝病などの治療向けに小分子やバイオ製剤を開発。同社の候補薬には多発性嚢胞腎治療の「KD034」と「Tesevatinib」などがある。本社はニューヨーク。  Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.
本社所在地 450 East 29th Street New York NY 10016 USA
代表者氏名 Tasos G. Konidaris
代表者役職名 Interim Chairman of the Board
電話番号 +1 212-308-6000
設立年月日 40422
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 116人
url www.kadmon.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -84.31500
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 368.03760
売上高 (百万ドル) 1.39600
企業価値(EV) (百万ドル) 343.00860
当期純利益 (百万ドル) -56.86300
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Kadmon Holdings Inc revenues decreased 89% to $1.4M. Net loss applicable to common stockholders excluding extraordinary items decreased 31% to $56.9M. Revenues reflect License and other revenue decrease of 90% to $705K Net sales decrease of 87% to $691K. Lower net loss reflects Loss on equity method investment decrease of 84% to $1.2M (expense).

 KDMNのテクニカル分析


 KDMNのニュース

   Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Kadmon, Echo Global, GreenSky, and Great Western Bancorp on behalf of Stockholders and Encourages Investors to Contact the Firm  2021/10/01 21:45:00 Intrado Digital Media
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Kadmon Holdings, Inc. (NASDAQ: KDMN), Echo Global Logistics, Inc. (NASDAQ: ECHO), GreenSky, Inc. (NASDAQ: GSKY), and Great Western Bancorp, Inc. (NYSE: GWB). Additional information about each potential action can be found at the link provided.
   Kadmon Holdings, Inc.: Kadmon Announces Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer''s 36th Annual Meeting  2021/10/01 12:08:00 FinanzNachrichten
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion
   KADMON HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN  2021/09/10 22:41:00 Business Wire
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed
   : Kadmon Holdings downgraded to neutral from buy at UBS  2021/09/10 15:31:00 MarketWatch
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
   ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kadmon Holdings, Inc.  2021/09/09 20:25:00 PR Newswire
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kadmon Holdings, Inc. (NASDAQ: KDMN) and its board of directors concerning the proposed acquisition of the company by Sanofi (NASDAQ: SNY). Stockholders will receive $9.50 for
   Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Kadmon, Echo Global, GreenSky, and Great Western Bancorp on behalf of Stockholders and Encourages Investors to Contact the Firm  2021/10/01 21:45:00 Intrado Digital Media
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Kadmon Holdings, Inc. (NASDAQ: KDMN), Echo Global Logistics, Inc. (NASDAQ: ECHO), GreenSky, Inc. (NASDAQ: GSKY), and Great Western Bancorp, Inc. (NYSE: GWB). Additional information about each potential action can be found at the link provided.
   Kadmon Holdings, Inc.: Kadmon Announces Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer''s 36th Annual Meeting  2021/10/01 12:08:00 FinanzNachrichten
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion
   KADMON HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN  2021/09/10 22:41:00 Business Wire
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed
   : Kadmon Holdings downgraded to neutral from buy at UBS  2021/09/10 15:31:00 MarketWatch
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
   ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kadmon Holdings, Inc.  2021/09/09 20:25:00 PR Newswire
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kadmon Holdings, Inc. (NASDAQ: KDMN) and its board of directors concerning the proposed acquisition of the company by Sanofi (NASDAQ: SNY). Stockholders will receive $9.50 for
   Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Kadmon, Echo Global, GreenSky, and Great Western Bancorp on behalf of Stockholders and Encourages Investors to Contact the Firm  2021/10/01 21:45:00 Intrado Digital Media
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Kadmon Holdings, Inc. (NASDAQ: KDMN), Echo Global Logistics, Inc. (NASDAQ: ECHO), GreenSky, Inc. (NASDAQ: GSKY), and Great Western Bancorp, Inc. (NYSE: GWB). Additional information about each potential action can be found at the link provided.
   Kadmon Holdings, Inc.: Kadmon Announces Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer''s 36th Annual Meeting  2021/10/01 12:08:00 FinanzNachrichten
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion
   KADMON HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN  2021/09/10 22:41:00 Business Wire
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed
   : Kadmon Holdings downgraded to neutral from buy at UBS  2021/09/10 15:31:00 MarketWatch
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
   ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kadmon Holdings, Inc.  2021/09/09 20:25:00 PR Newswire
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kadmon Holdings, Inc. (NASDAQ: KDMN) and its board of directors concerning the proposed acquisition of the company by Sanofi (NASDAQ: SNY). Stockholders will receive $9.50 for

 関連キーワード  (医薬品 米国株 KADMON HOLDINGS KDMN )

 twitter  (公式ツイッターやCEOツイッターなど)